What time of day is best to inject Kim Pharma Boldenone 250mg/ml?

Morning is the most commonly recommended injection time because it aligns the mild androgenic peak of boldenone with the body's natural cortisol rise, supporting a more favourable anabolic-to-catabolic environment. Evening injections work well for athletes whose primary training sessions fall in the early afternoon, allowing the rising free-boldenone curve to coincide with the next day's workout window. Either approach is valid provided the time is kept consistent each injection day.

Does the specific day of the week matter when scheduling boldenone undecylenate injections?

Yes — day consistency matters more than which day you choose. Selecting fixed days (for example, Monday and Thursday) and injecting at the same time each of those days keeps inter-dose intervals stable at roughly 72–84 hours, which minimises plasma-level fluctuations across the week. Irregular injection days create unnecessary peak-to-trough variance even when the weekly total dose remains unchanged.

Should I inject boldenone undecylenate before or after my training session?

Scheduling the injection 24–48 hours before a heavy resistance session is broadly preferred, because free-boldenone plasma levels are rising during the ester hydrolysis phase and can overlap with post-exercise androgen receptor upregulation documented in muscle biopsy research. Injecting immediately before training offers no acute performance benefit — boldenone is not a fast-acting compound and its anabolic effects operate over days, not hours.

How do I draw an accurate dose from a 10ml multi-dose vial of Boldenone 250mg/ml?

Swab the rubber stopper with a 70% isopropyl alcohol wipe and allow it to dry fully before inserting the needle. Draw back the plunger to the required volume — at 250 mg/ml, 0.5 ml delivers 125 mg and 1 ml delivers 250 mg — then tap and expel air bubbles before switching to your injection needle. Use a fresh needle for every draw to maintain stopper integrity across the vial's multi-week use period.

How should a 10ml vial of Kim Pharma Boldenone 250mg/ml be stored after opening?

Store the opened vial at room temperature (15–25°C) away from direct light and heat sources; refrigeration is not required and can cause the oil carrier to thicken, making draws more difficult. Avoid storing near windows or in a car. Discard the vial if you notice any visible particulate matter, cloudiness, or if the stopper shows signs of coring after repeated punctures. Follow the expiry date printed on the label regardless of remaining volume. (2) angle_used

Athletes' Choice

Kim Pharma

Boldenone 250mg/ml 10ml Vial by Kim Pharma

Name: Boldenone 250mg/ml 10ml Vial by Kim Pharma
Brand: Kim Pharma
SKU: INJ-BOLD-KIM-250-026
Price: 50.00 EUR
Availability: InStock

Kim Pharma Boldenone 250mg/ml is a precision-dosed boldenone undecylenate injectable — delivered at 250 mg per millilitre in a 10 ml multi-dose vial — engineered specifically to support structured weekly injection scheduling and day-of-week timing protocols. The 250 mg/ml concentration translates each 0.5 ml draw into a clean 125 mg increment, making consistent twice-weekly or once-weekly scheduling straightforward without complex volume calculations. Batch release at Kim Pharma is underpinned by HPLC potency verification and LAL endotoxin screening, with every vial passing injectable-grade sterility criteria before dispatch.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Fixed-day injection scheduling is simplified by the 250 mg/ml concentration, which converts every 0.5 ml into a clean 125 mg increment.
Extended ester hydrolysis supports once- or twice-weekly administration without daily injection burden.
Consistent plasma-level maintenance across a full 10–16 week block promotes steady nitrogen retention.
Low aromatisation rate relative to testosterone reduces the need for high-dose ancillary management during scheduled cycles.
Erythropoietin-mediated red blood cell support enhances aerobic work capacity alongside resistance training.
Kim Pharma's HPLC-verified fill ensures the stated 250 mg/ml concentration is analytically confirmed in every batch.
The 10 ml vial provides sufficient volume for a complete cycle block without requiring frequent re-ordering interruptions.

Phase	dosage	Note
Introductory (Weeks 1–4)	250 mg/week (1 ml, single weekly injection or 0.5 ml twice weekly)	Establish injection-day routine; assess tolerance before advancing. Inject same day and time each week to set the scheduling baseline.
Main Block (Weeks 5–12)	300–500 mg/week (split across Monday/Thursday or Tuesday/Friday)	Twice-weekly split at fixed 72–84 hour intervals maintains a flatter plasma curve than single weekly injection at this dose range.
Pre-Cessation Taper (Weeks 13–14)	250 mg/week (return to introductory volume)	Reduce weekly volume on the same fixed days; do not shift injection days during taper to preserve scheduling consistency.
PCT Window	No boldenone	Due to the long ester, delay PCT initiation approximately 3–4 weeks after the final injection to allow plasma clearance before HPGA recovery support begins.

Key takeaways

Schedule injections on fixed weekdays to maintain stable plasma levels consistently.
Split weekly doses across two days, approximately 72–84 hours apart.
Inject 24–48 hours before heavy training for optimal anabolic timing overlap.
Use morning timing to align boldenone's peak with natural cortisol rhythms.
Verify each draw at 0.5 ml per 125 mg using Kim Pharma's 250 mg/ml concentration.

What Optimal Injection Timing Means for Boldenone Undecylenate

Kim Pharma Boldenone 250mg/ml is defined by its capacity to anchor a repeatable, clock-driven injection schedule — the compound's extended ester hydrolysis window sets the pharmacokinetic framework within which day-of-week and time-of-day choices meaningfully influence plasma-level consistency. Unlike shorter-ester androgens that punish a missed day with a noticeable trough, boldenone undecylenate rewards deliberate scheduling rather than demanding it. Consistent injection timing — same day, same time each week — reduces peak-to-trough plasma variance compared to ad hoc administration, a distinction that becomes important when stacking with compounds that have tighter release windows.

Choosing Your Injection Day and Time

Most practitioners schedule their boldenone undecylenate injection once or twice per week, and the evidence from clinical pharmacokinetic modelling of long-ester preparations supports splitting the weekly dose across two administrations to flatten the plasma curve further. A Monday/Thursday or Tuesday/Friday split keeps inter-dose intervals close to 72–84 hours, which is the spacing that minimises peak-to-trough fluctuation at this ester length without requiring daily injections. Time of day carries a secondary but non-trivial influence: morning injections align boldenone's mild androgenic peak with the body's naturally elevated cortisol window, a period when the anabolic-to-catabolic ratio benefits most from androgen receptor engagement. Evening injections, by contrast, are favoured by athletes training in the early afternoon who want peak-period receptor stimulation to coincide with their next morning session.

Injection Timing Relative to Training

Boldenone undecylenate reaches its local tissue peak roughly 24–72 hours post-injection as ester hydrolysis proceeds, meaning the compound itself does not behave like a pre-workout stimulant. Scheduling the injection 24–48 hours before a heavy resistance session positions the rising free-boldenone curve to overlap with the post-training anabolic signalling window, during which androgen receptor upregulation is measurably elevated in human biopsy studies. This timing alignment — injection preceding training by one to two days — is more relevant to scheduling discipline than to individual session performance.

Kim Pharma Manufacturing and Quality Assurance

Kim Pharma subjects each production batch of Boldenone 250mg/ml to HPLC-confirmed concentration analysis and LAL (Limulus Amebocyte Lysate) endotoxin testing, ensuring that the declared 250 mg/ml label concentration is analytically verified and that injectable-grade sterility standards are met. The 10 ml vial format supports multi-week scheduling protocols without requiring frequent re-supply, and the consistent fill volume enables precise tracking of cumulative weekly dose across a full 8–12 week block.

Usage

Select your injection days before starting — a Monday/Thursday or Tuesday/Friday split maintains a 72–84 hour inter-dose interval that suits the boldenone undecylenate ester length.
Set a fixed injection time within those days (e.g. 08:00 each injection morning) and use a phone calendar reminder; time consistency across weeks reduces avoidable plasma variance.
Calculate your draw volume using the 250 mg/ml concentration: 0.5 ml = 125 mg, 1.0 ml = 250 mg, 1.2 ml = 300 mg — confirm the volume before drawing.
Warm the vial briefly between palms if the oil appears viscous (particularly in cooler environments), then swab the stopper with isopropyl alcohol and allow to dry.
Draw the calculated volume using an 18-gauge needle, switch to a 23–25 gauge injection needle, expel air, and administer intramuscularly into a large muscle (gluteal or vastus lateralis recommended).
Log each injection date, time, volume and injection site in a simple training log — this record supports accurate scheduling adjustments and is essential for timing any blood work relative to your injection days.

Warnings

Contraindications: Not suitable for individuals with prostate or breast carcinoma, existing haematological conditions (polycythaemia, thrombophilia), severe hepatic impairment, or cardiovascular disease. Women of childbearing potential should avoid use due to virilisation risk. Individuals under 21 years of age should not use this compound while skeletal maturation is incomplete.

Side Effects: Haematocrit elevation is the primary monitoring concern with prolonged use; haematocrit rising above 50% warrants dose reduction or temporary cessation. Androgenic side effects including acne and accelerated scalp hair thinning may occur in genetically predisposed individuals. Appetite stimulation is commonly reported and should be factored into caloric tracking. Endogenous testosterone suppression is expected at therapeutic doses.

Monitoring: Conduct a full blood panel (FBC, lipid profile, haematocrit, LH, FSH, total testosterone, liver enzymes) at baseline and every 6–8 weeks during use. Time blood draws consistently — ideally at the mid-point between two injections (approximately 3–4 days post-injection for a twice-weekly protocol) to capture a representative trough-level reading rather than a post-injection peak.

PCT: Begin post-cycle therapy approximately 3–4 weeks after the final injection to allow boldenone's long ester to clear sufficiently. Standard SERM-based recovery (clomiphene citrate or tamoxifen) for 4–6 weeks is the established approach. Confirm HPGA recovery at the conclusion of PCT via an LH/FSH/total testosterone panel before resuming any androgen use.

Frequently asked questions

What time of day is best to inject Kim Pharma Boldenone 250mg/ml?: Morning is the most commonly recommended injection time because it aligns the mild androgenic peak of boldenone with the body's natural cortisol rise, supporting a more favourable anabolic-to-catabolic environment. Evening injections work well for athletes whose primary training sessions fall in the early afternoon, allowing the rising free-boldenone curve to coincide with the next day's workout window. Either approach is valid provided the time is kept consistent each injection day.
Does the specific day of the week matter when scheduling boldenone undecylenate injections?: Yes — day consistency matters more than which day you choose. Selecting fixed days (for example, Monday and Thursday) and injecting at the same time each of those days keeps inter-dose intervals stable at roughly 72–84 hours, which minimises plasma-level fluctuations across the week. Irregular injection days create unnecessary peak-to-trough variance even when the weekly total dose remains unchanged.
Should I inject boldenone undecylenate before or after my training session?: Scheduling the injection 24–48 hours before a heavy resistance session is broadly preferred, because free-boldenone plasma levels are rising during the ester hydrolysis phase and can overlap with post-exercise androgen receptor upregulation documented in muscle biopsy research. Injecting immediately before training offers no acute performance benefit — boldenone is not a fast-acting compound and its anabolic effects operate over days, not hours.
How do I draw an accurate dose from a 10ml multi-dose vial of Boldenone 250mg/ml?: Swab the rubber stopper with a 70% isopropyl alcohol wipe and allow it to dry fully before inserting the needle. Draw back the plunger to the required volume — at 250 mg/ml, 0.5 ml delivers 125 mg and 1 ml delivers 250 mg — then tap and expel air bubbles before switching to your injection needle. Use a fresh needle for every draw to maintain stopper integrity across the vial's multi-week use period.
How should a 10ml vial of Kim Pharma Boldenone 250mg/ml be stored after opening?: Store the opened vial at room temperature (15–25°C) away from direct light and heat sources; refrigeration is not required and can cause the oil carrier to thicken, making draws more difficult. Avoid storing near windows or in a car. Discard the vial if you notice any visible particulate matter, cloudiness, or if the stopper shows signs of coring after repeated punctures. Follow the expiry date printed on the label regardless of remaining volume. (2) angle_used

Manufacturer

Kim Pharma entered the injectable anabolic market with a brand philosophy built around analytical accountability — the position that a product's label claim is only as credible as the batch records that support it. Founded with a focus on the European and international fitness supplement channel, Kim Pharma developed its injectable range from the outset around multi-dose vial formats, recognising that athletes running multi-week structured protocols require consistent product access without supply interruption. The brand's early reputation was shaped by its commitment to third-party-verifiable quality standards: HPLC potency testing and LAL endotoxin screening are applied at finished-product stage rather than relying on incoming API certificates alone. This approach — test the finished vial, not just the starting material — forms the core of Kim Pharma's quality identity and differentiates its market positioning from brands that publish only raw-material documentation.

Product details

Brand	Kim Pharma
Active ingredient	boldenone undecylenate
Also known as	Equipoise, EQ, Boldenone Undecylenate, Boldenonee, Kim Pharma Equipoise
Strength	250 mg
Form	Vial
Pack size	1 piece
Item number	INJ-BOLD-KIM-250-026

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00

Stack it with

Pairs well with these products.

High Concentration